Finnish Pharma Co. Faron Launches €40M Rights Offer
Faron Pharmaceuticals said Tuesday it has launched a program to raise approximately €40 million ($46.5 million) to support clinical trials for its main cancer drug candidate and finance its operating costs...To view the full article, register now.
Already a subscriber? Click here to view full article